Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine vs Placebo for Prevention of Mood Episodes in Bipolar I Disorder
NCT00550407Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in bipolar I disorder, sponsored by GSK. Started Nov 2007; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00550407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550407.